3[8]Schwarz A. New aspects of the treatment of nephrotic syndrome. J Am Soc Nephrol,2001,12 Suppl(17):S44- 7 被引量：1
4[10]Marsh JB. Lipoprotein metabolism in the nephrotic syndrome. Front Biosci,2002,7:326- 38 被引量：1
5[11]Wheeler DC.Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins. J Nephrol,2001,14Supp(14):S70- 5 被引量：1
6[12]Prata MM,Nogueira AC, Pinto JR, et al. Long- term effect of lovastatin on lipoprotein profile in patients with primary nephroic syndrome. Clin Nephrol,1994,41 (5):277- 83 被引量：1
7[13]Olbricht C J, Wanner C, Thiery J, Basten A. Simvastatin in nephroitic syndrome. Simvastatin in Nephrofic Syndrome Study Group. Kidney Int Suppl,1999,71: S113- 6 被引量：1
8[14]Spitalewitz S, Potash JG,Cattran D, Wright N .Treatment of hy pefiipidemia in the nephrofic syndrome: the offects of pravastatin therapy. Am J Kidney Dis,1993,22(1): 143- 50 被引量：1
9[15]Kies Fk ,Bahner U, Teschner M ,et al. Efficiency of 1- year treatment with fiuvastatin in hypefiipidemic patients with nephrotic syndrome. Am J Nephrol,1999,19(4):492- 4 被引量：1
